Kazumi Nishino

机构：Osaka International Cancer Institute · ORCID：0000-0003-2000-7472

发表论文 329 篇 · 总被引 4489 次 · h-index 35

代表论文

Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancer (2025 · Translational Lung Cancer Research · 被引 3)
Mutation testing, treatment patterns, and outcomes in patients with unresectable stage III EGFR-mutated non-small cell lung cancer treated with chemoradiotherapy: Final analysis of a global real–world study (2025 · Lung Cancer · 被引 2)
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer (2026 · European Journal of Cancer · 被引 1)
Multicenter retrospective study of selpercatinib treatment for advanced or recurrent RET fusion-positive non-small cell lung cancer in Japan (2025 · Investigational New Drugs · 被引 1)
RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic EGFR -mutated NSCLC (2025 · Future Oncology · 被引 1)
First-line Selpercatinib or Chemotherapy and Pembrolizumab in Patients From East Asia With RET Fusion–Positive NSCLC: A LIBRETTO-431 Subgroup Analysis (2025 · JTO Clinical and Research Reports · 被引 1)